Smartlab Europe

Press Releases

Thermo Fisher Scientific Further Expands COVID-19 Test Portfolio with Two New Antibody Tests

Thermo Fisher Scientific Inc., the world leader in serving science, introduced two new SARS-CoV-2 antibody tests: the Thermo Scientific OmniPATH COVID-19 Total Antibody ELISA test, and the Thermo Scientific EliA SARS-CoV-2-Sp1 IgG test. These new tests for detecting COVID-19...

Mapi Pharma Announces Commissioning of a Vaccine Production Facility to Support the Supply of COVID-19 Vaccines to Israel and EU Countries

Mapi Pharma Ltd., a fully integrated, late clinical stage biopharmaceutical company, announced that it will dedicate capacity at its manufacturing facility to support the global effort to provide COVID-19 vaccination to Israel, the EU and globally. Mapi Pharma has state-of-the-art...

Sharp invests $10M in biologics and injectables packaging equipment

Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has announced a further investment of $10M in equipment capabilities to directly support client demand in the biologics and injectables market. The investment includes...

Noble and Aptar Pharma Launch AdhereIT, a Connected Medical Device Solution for Disease Management Adherence and Onboarding Patients

Noble and Aptar Pharma are pleased to announce the launch of AdhereIT™ - a connected, intuitive and user-friendly onboarding solution for the growing number of patients with chronic conditions who use autoinjectors to administer their medications at home. AdhereIT™...

AirBridgeCargo delivers over 500,000 vials with human albumin

AirBridgeCargo Airlines (ABC), one of the leaders in transportation of temperature-sensitive shipments, has organized dedicated pharma charter flight from Leipzig (Germany) to Guangzhou (China) through Novosibirsk (Russia). ABC’s long-standing partner, Kuehne+Nagel, safely delivered 19 ULDs from Vienna (Austria) to the...

Recipharm signs agreement with Arcturus Therapeutics to support the manufacture of LUNAR -COV19 vaccine candidate

Recipharm, a leading contract development and manufacturing organisation (CDMO) has entered into an agreement with Arcturus Therapeutics, a leading U.S. based clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver...

Eisai enters joint research pact with four research organizations in Japan for development of therapeutics for novel COVID-19

Eisai Co Ltd announced that it has entered into a joint research agreement with four research organizations (KAN Research Institute, National Center for Global Health and Medicine, Nagasaki University, and Yokohama City University) in Japan concerning the “Development of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »